Linked e-resources
Details
Table of Contents
pt. 1. Disease burden, current treatments, medical needs, and strategic approaches
pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery
pt. 3. Validation and selection of drug targets in kinetoplasts
pt. 4. Examples of target-based approaches and compounds under consideration.
pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery
pt. 3. Validation and selection of drug targets in kinetoplasts
pt. 4. Examples of target-based approaches and compounds under consideration.